Loading…
The influence of hypertension management on frailty prevention among older persons aged 65 and over: a systematic review
Background Frailty and hypertension are interrelated, but it remains unclear whether this relationship is modified by antihypertensive drugs. Methods and results A systematic review of PubMed and Web of Science databases was performed to review the influence of hypertension management on preventing...
Saved in:
Published in: | Aging clinical and experimental research 2022-11, Vol.34 (11), p.2645-2657 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Frailty and hypertension are interrelated, but it remains unclear whether this relationship is modified by antihypertensive drugs.
Methods and results
A systematic review of PubMed and Web of Science databases was performed to review the influence of hypertension management on preventing the occurrence or progression of frailty in older people aged 65 and over. Studies providing information on this association regardless of the study setting, or definition of hypertension and frailty were included. Among the initial 2298 articles identified, 7 were included in the review. Three observational studies assessed the association between frailty and hypertension. Two of them reported no relationship between Aldosterone Antagonists use and frailty prevention. No relationship between BP and incidence frailty after adjustment for hypertension treatment was observed in two other articles. An indirect relationship was reported in the RCTs included. Higher AT11RaAb levels (control group), can lead to a generalized weakness/frailty risk shown by a decrease in grip strength (
r
= –0.57,
p
|
---|---|
ISSN: | 1720-8319 1594-0667 1720-8319 |
DOI: | 10.1007/s40520-022-02247-0 |